title: Cancer procoagulant (CP) in lung cancer.
abstract: Lung cancers (squamous cell carcinoma, microcellular carcinoma, macrocellular carcinoma and adenocarcinoma) show procoagulant activity. It mainly depends on the presence of cancer procoagulant (CP) in lung cancer cells.
authors.affiliation: Department of Oncology, Medical Academy of Białystok.
authors.forename: M
authors.initials: M
authors.lastname: Rucińska
authors.forename: Z
authors.initials: Z
authors.lastname: Skrzydlewski
authors.forename: E
authors.initials: E
authors.lastname: Zaremba
authors.forename: M
authors.initials: M
authors.lastname: Furman
authors.forename: I
authors.initials: I
authors.lastname: Kasacka
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000737:chemistry*; D003546:Cysteine Endopeptidases / Q000032:analysis*; D006801:Humans; D008168:Lung / Q000737:chemistry; D008175:Lung Neoplasms / Q000737:chemistry*; D009363:Neoplasm Proteins / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D003546:Cysteine Endopeptidases; C030910:cancer procoagulant